Viridian Therapeutics
VRDN
VRDN
123 hedge funds and large institutions have $770M invested in Viridian Therapeutics in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 55 increasing their positions, 36 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
31% less capital invested
Capital invested by funds: $1.12B → $770M (-$351M)
89% less call options, than puts
Call options by funds: $133K | Put options by funds: $1.17M
89% less funds holding in top 10
Funds holding in top 10: 9 → 1 (-8)
Holders
123
Holding in Top 10
1
Calls
$133K
Puts
$1.17M
Top Buyers
| 1 | +$25.8M | |
| 2 | +$19.4M | |
| 3 | +$8.11M | |
| 4 |
EP
Eversept Partners
New York
|
+$6.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.74M |
Top Sellers
| 1 | -$20.2M | |
| 2 | -$11.7M | |
| 3 | -$4.8M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$4M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$3.42M |